Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Capital Expenditures: 2024-2025

Historic Capital Expenditures for Kura Oncology (KURA) over the last 2 years, with Sep 2025 value amounting to $2.6 million.

  • Kura Oncology's Capital Expenditures was N/A to $2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.7 million, marking a year-over-year change of. This contributed to the annual value of $472,000 for FY2024, which is 180.95% up from last year.
  • Kura Oncology's Capital Expenditures amounted to $2.6 million in Q3 2025, which was up 76.06% from $1.5 million recorded in Q2 2025.
  • Kura Oncology's 5-year Capital Expenditures high stood at $2.6 million for Q3 2025, and its period low was $16,000 during Q2 2024.
  • For the 2-year period, Kura Oncology's Capital Expenditures averaged around $798,167, with its median value being $332,000 (2024).
  • Data for Kura Oncology's Capital Expenditures shows a peak YoY surged of 9,012.50% (in 2025) over the last 5 years.
  • Over the past 2 years, Kura Oncology's Capital Expenditures (Quarterly) stood at $372,000 in 2024, then spiked by 9,012.50% to $2.6 million in 2025.
  • Its Capital Expenditures was $2.6 million in Q3 2025, compared to $1.5 million in Q2 2025 and $292,000 in Q1 2025.